Protagonist Therapeutics, Inc. (PTGX) Earnings Report - Discounting Cash Flows
PTGX
Protagonist Therapeutics, Inc.
PTGX (NASDAQ)
Period Ending: 2026
05-04
2026
02-20
2025
11-06
2025
08-06
2025
05-06
2025
02-21
2024
11-07
2024
08-06
2024
05-07
2024
02-27
2023
11-02
2023
08-03
2023
05-04
2023
03-15
2022
11-08
2022
08-04
2022
05-04
2022
02-28
2021
11-03
2021
08-04
2021
05-04
2021
03-10
2020
11-04
2020
08-06
2020
05-07
2020
03-10
2019
11-06
2019
08-07
2019
05-08
2019
03-12
2018
11-06
2018
08-07
2018
05-09
2018
03-07
2017
11-06
2017
08-08
2017
05-10
2017
03-07
2016
11-14
2016
09-15
2016
08-12
2015
12-30
2015
09-29
2015
06-29
2015
03-30
Actual EPS - - -0.62 -0.55 -0.19 1.98 -0.54 -0.50 3.26 0.44 -0.58 -0.68 -0.67 -0.69 -0.64 -0.84 -0.43 -0.77 -0.70 -0.69 -0.54 -0.48 -0.21 -0.59 -0.72 -0.63 -0.61 -1.18 -0.58 -0.57 -0.38 -0.41 -0.36 -0.15 -0.29 -0.89 -0.84 -0.67 -0.87 -19.07 -2.00 -0.93 -0.59 -0.55 -0.46
Estimated EPS - -0.53 -0.59 -0.53 -0.50 0.06 -0.59 -0.50 1.19 0.03 -0.68 -0.65 -0.69 -0.67 -0.94 -0.99 -0.67 -0.79 -0.67 -0.62 -0.57 -0.47 -0.61 -0.57 -0.64 -0.64 -0.75 -0.27 -0.65 -0.42 -0.40 -0.30 -0.24 -0.36 -0.95 -0.92 -0.64 -0.52 -0.49 -0.77 - - - - -
Actual Revenue - - 4.71 5.55 28.32 170.6 4.67 4.17 255 60 - - - - - 0.859 25.72 8.62 10.29 2.27 6.19 5.65 13.11 6.22 3.65 2.72 4.14 8.19 1.56 2.35 6.12 11.67 10.78 11.28 8.78 - - - - - - - - - -
Estimated Revenue - - 34.91 8.43 6.56 81.01 38.81 8 120 40 38.33 8.33 2 5 - 0.46 21.18 5.07 2.03 5.17 3.12 - 9.44 6.01 3.5 2.81 4.82 1.94 1.59 1.94 5.96 9.97 8.68 26.32 21.5 - - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program